Osteoclasts and the immune system (Q37489600)

20 August 2017

1 reference

title

Osteoclasts and the immune system (English)

1 reference

20 August 2017

Tomoki Nakashima

1

1 reference

20 August 2017

Hiroshi Takayanagi

series ordinal

2

1 reference

20 August 2017

language of work or name

1 reference

20 May 2009

1 reference

Journal of Bone and Mineral Metabolism

20 August 2017

published in

1 reference

20 August 2017

volume

27

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

519-529

1 reference

c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0089-Z

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0089-Z

Osteoclasts are essential for TNF-alpha-mediated joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0089-Z

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0089-Z

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

21 January 2018

1 reference

12 December 2020

The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator.

1 reference

12 December 2020

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

1 reference

12 December 2020

Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood Leukocytes

1 reference

12 December 2020

Transcriptional regulation by calcium, calcineurin, and NFAT

1 reference

12 December 2020

The IL-23/IL-17 axis in inflammation

1 reference

12 December 2020

NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism

1 reference

12 December 2020

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

1 reference

12 December 2020

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

1 reference

12 December 2020

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

12 December 2020

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

1 reference

12 December 2020

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

12 December 2020

Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase

1 reference

12 December 2020

Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint

1 reference

12 December 2020

The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis

1 reference

12 December 2020

CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE.

1 reference

12 December 2020

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

1 reference

12 December 2020

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

1 reference

12 December 2020

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin.

1 reference

12 December 2020

Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand

1 reference

12 December 2020

Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.

1 reference

12 December 2020

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

1 reference

12 December 2020

A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis

1 reference

12 December 2020

Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures

1 reference

12 December 2020

Regulation of cancer cell migration and bone metastasis by RANKL.

1 reference

12 December 2020

PPAR-gamma regulates osteoclastogenesis in mice

1 reference

12 December 2020

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

12 December 2020

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

12 December 2020

Osteoimmunology: interplay between the immune system and bone metabolism

1 reference

12 December 2020

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

1 reference

12 December 2020

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

1 reference

12 December 2020

Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

1 reference

12 December 2020

The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization

1 reference

12 December 2020

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 December 2020

Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations

1 reference

12 December 2020

TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts

1 reference

12 December 2020

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

Anti-TNF-alpha therapies: the next generation

1 reference

12 December 2020

DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.

1 reference

12 December 2020

The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.

1 reference

12 December 2020

Activated T lymphocytes support osteoclast formation in vitro

1 reference

12 December 2020

RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis.

1 reference

12 December 2020

Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation

1 reference

12 December 2020

Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice

1 reference

12 December 2020

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling

1 reference

12 December 2020

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

12 December 2020

An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand

1 reference

12 December 2020

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

1 reference

12 December 2020

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis

1 reference

12 December 2020

Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL.

1 reference

12 December 2020

Osteoprotegerin deficiency and juvenile Paget's disease

1 reference

12 December 2020

Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.

1 reference

12 December 2020

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

12 December 2020

Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts

1 reference

12 December 2020

Interleukin 6: from bench to bedside

1 reference

12 December 2020

Osteoblastic cells are involved in osteoclast formation.

1 reference

12 December 2020

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination

1 reference

12 December 2020

PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.

1 reference

12 December 2020

RANK is essential for osteoclast and lymph node development

1 reference

12 December 2020

Th17: an effector CD4 T cell lineage with regulatory T cell ties

1 reference

12 December 2020

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

1 reference

12 December 2020

NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1

1 reference

12 December 2020

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

1 reference

12 December 2020

Fos/AP-1 proteins in bone and the immune system

1 reference

12 December 2020

Denosumab in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells

1 reference

12 December 2020

Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta

1 reference

12 December 2020

RANK-L and RANK: T cells, bone loss, and mammalian evolution

1 reference

12 December 2020

Reaching a genetic and molecular understanding of skeletal development

1 reference

12 December 2020

Requirement for NF-kappaB in osteoclast and B-cell development

1 reference

12 December 2020

Dickkopf-1 is a master regulator of joint remodeling

1 reference

12 December 2020

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

12 December 2020

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

1 reference

12 December 2020

RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation

1 reference

12 December 2020

FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner

1 reference

12 December 2020

TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation

1 reference

12 December 2020

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

1 reference

12 December 2020

Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts

1 reference

12 December 2020

The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance.

1 reference

12 December 2020

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

12 December 2020

Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis

1 reference

12 December 2020

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

12 December 2020

NFAT signaling: choreographing the social lives of cells

1 reference

12 December 2020

Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis

1 reference

12 December 2020

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

1 reference

12 December 2020

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

1 reference

12 December 2020

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

1 reference

12 December 2020

10.1007/S00774-009-0089-Z

Identifiers

DOI

1 reference

release_v3lvbyqxfzgn7a6le4i7d36wee

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v3lvbyqxfzgn7a6le4i7d36wee

24 November 2022

mapped directly with Wikidata item

1 reference